EGFR and non-small cell lung carcinoma: In order to determine whether the weighted combination of these 4 TCR clones can predict the prognosis of stage II/III patients with an EGFR mutation with NSCLC, we performed univariate and multivariate Cox proportional hazard regression analyses.